$SYRA

$0.93 +$0.01 (0.98%) Close

$SYRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 13.8M shares outstanding

Who owns SYRA?

By type of holder

Institutions 0.0% Insiders 0.0% Everyone else 100.0%

Concentration Top 1 holders own 5.1%

Johnson Neil Lawrence 5.1%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Syra Health Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+289.7%

+57.37% a year

Each share's claim on the business

−74.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $194K

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding SYRA.

Super Investors

Investment managers reporting SYRA on Form 13F

No 13F manager reports holding SYRA yet.

Institutional Funds

Mutual funds and ETFs reporting SYRA on Form N-PORT; together they hold 0.0% of the company

No fund reports holding SYRA yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JN Johnson Neil Lawrence 5%+ holder 13D · 6.2%	700.3K	5.06%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company5.060% Disclosed stake13D · 6.2% View the 13D/G filing →

Johnson Neil Lawrence

5%+ holder13D · 6.2%

700.3K

% of company

5.06%

Change vs last qtr

—

Held since

—

Comments